Residual Exacerbations With Mepolizumab — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Residual Exacerbations With Mepolizumab — Stella

Recruiting

Back to Asthma trials

Trial locations(1 site)

Canada

Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec

Key details

Sponsor

Laval University

Collaborators

GlaxoSmithKline

Enrollment target

~60 participants

Started

July 2021

Primary completion

January 2027

Age range

18 Years – 90 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov